title: Dual antiplatelet therapy plus oral anticoagulation: how does hemorrhagic risk impact stent selection?
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Giugliano
authors.forename: Amir S
authors.initials: AS
authors.lastname: Lotfi
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008670:Metals; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D011474:Prosthesis Design; D018570:Risk Assessment; D015607:Stents; D013997:Time Factors
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D008670:Metals; D010975:Platelet Aggregation Inhibitors